专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US06200331B1 Electroconvulsive therapy testing and training device 有权
标题翻译：电惊厥治疗试验和训练装置
公开(公告)号：US06200331B1
公开(公告)日：2001-03-13
申请号：US09378817
申请日：1999-08-23
申请人： Conrad Melton Swartz , Richard Stephen Abrams
发明人： Conrad Melton Swartz , Richard Stephen Abrams
IPC分类号： A61N100
CPC分类号： A61N1/08
摘要： A free-standing device for the testing of ECT (electroconvulsive therapy) instruments, and for training doctors in using such instruments, includes circuits to generate electrical wave forms which simulate the EEG (electroencephalograph) detectable brain waves, EMG (electromyograph) muscle activity and heart beats of a patient undergoing ECT. In one embodiment the ECT output leads of the ECT instrument are plugged into the device, the training doctor selects the ECT current and the device generates response EEG and EMG waveforms. It also measures the current and displays its measurement as a test of the accuracy of the stimulus selection controls of the ECT instrument.
摘要翻译：用于测试ECT（电惊厥治疗）仪器和用于训练医生使用这些仪器的独立设备包括产生电波形的电路，其模拟EEG（脑电图）可检测脑波，EMG（肌电图）肌肉活动和经历ECT的患者心跳。在一个实施例中，ECT仪器的ECT输出引线插入到设备中，训练医生选择ECT电流，并且设备产生响应EEG和EMG波形。它还测量电流并显示其测量值作为ECT仪器的刺激选择控制精度的测试。

2. 发明授权

US6117066A Prevention of seizure arising from medical magnetoictal non-convulsive stimulation therapy 失效
标题翻译：预防医学磁性非惊厥刺激治疗引起的癫痫发作
公开(公告)号：US6117066A
公开(公告)日：2000-09-12
申请号：US159045
申请日：1998-09-23
申请人： Richard Stephen Abrams , Conrad Melton Swartz
发明人： Richard Stephen Abrams , Conrad Melton Swartz
IPC分类号： A61N1/08 , A61N2/00 , A61N2/02 , A61N2/04 , A61N1/00
CPC分类号： A61N1/08 , A61N2/006 , A61N2/02
摘要： In non-convulsive magnetic stimulation therapy a patient is treated with magnetic pulses from a coil placed proximate the patient's head as a treatment of certain neurologic and psychiatric disorders. A set of EEG (electroencephalograph) electrodes on the patient's scalp are switched on during pauses in the electrical pulse train to the coil. If epilepsy-like brain wave spikes and/or sharp waves are detected by the EEG, a warning is given, treatment is halted and an anti-convulsive medicine may be administered.
摘要翻译：在非惊厥性磁刺激疗法中，患者接受患者头部附近的线圈的磁脉冲治疗，以治疗某些神经和精神疾病。患者头皮上的一组EEG（脑电图）电极在电脉冲串到线圈的暂停期间被接通。如果EEG检测到癫痫样脑波峰值和/或尖锐波，则会发出警告，停止治疗，并施用抗惊厥药。

3. 发明授权

US6039046A Single-use oral protector especially for use in electroconvulsive therapy 有权
标题翻译：一次性口服保护剂，特别适用于电惊厥治疗
公开(公告)号：US6039046A
公开(公告)日：2000-03-21
申请号：US290102
申请日：1999-01-12
申请人： Conrad Melton Swartz , Richard Stephen Abrams
发明人： Conrad Melton Swartz , Richard Stephen Abrams
IPC分类号： A61C5/14
CPC分类号： A61C5/14
摘要： An oral protector, especially for use by patients during electroconvulsive therapy (ECT) consists of a flat unitary member which is preferably stamped from a flat sheet of material. The protector is elastic and formed of a closed-cell material, such as polyurethane plastic resin or artificial rubber. It has an elongated, generally elliptical shaped central opening which acts as an air passage.
摘要翻译：特别是在电惊厥治疗（ECT）期间由患者使用的口腔保护器由平坦的整体构件组成，其优选地从平板材料冲压。保护器是弹性的，并且由诸如聚氨酯塑料树脂或人造橡胶的闭孔材料形成。它具有细长的，大致椭圆形的中心开口，充当空气通道。

4. 发明授权

US5798393A Betaxolol hydrochloride for the treatment of anxiety disorders 失效
标题翻译：盐酸倍他洛尔治疗焦虑症
公开(公告)号：US5798393A
公开(公告)日：1998-08-25
申请号：US627685
申请日：1996-04-02
申请人： Conrad Melton Swartz
发明人： Conrad Melton Swartz
IPC分类号： A61K31/137 , A61K31/135
CPC分类号： A61K31/137
摘要： The compound betaxolol has the chemical formula: 1-�4�2-cyclopropylmethoxy)ethyl!phenoxy!-3-�1-methylethyl)amino!-2-propanol. It is administered, preferably orally, once per day in 4-12 mg. tablets for the treatment of symptoms of anxiety disorder in human patients. Such symptoms include those present in Generalized Anxiety Disorder (GAD), which include somatic symptoms such as panic, palpitations and pounding heart.
摘要翻译：化合物倍他洛尔具有化学式：1- [4 [2-环丙基甲氧基）乙基]苯氧基] -3- [1-甲基乙基]氨基] -2-丙醇。以4-12mg每天一次施用，优选口服给药。片剂用于治疗人类患者焦虑症状。这些症状包括存在于广泛性焦虑症（GAD）中的症状，其包括躯体症状，如恐慌，心悸和冲击性心脏。

5. 发明授权

US06218395B1 Centrally-acting beta-blockers and serotonin-enhancers for the treatment of anxiety disorders and adjustment disorders with anxiety 失效
标题翻译：中枢作用的β-受体阻滞剂和5-羟色胺增强剂，用于治疗焦虑症和焦虑症调节障碍
公开(公告)号：US06218395B1
公开(公告)日：2001-04-17
申请号：US09366130
申请日：1999-08-02
申请人： Conrad Melton Swartz
发明人： Conrad Melton Swartz
IPC分类号： A61K4506
CPC分类号： A61K31/135 , A61K31/505 , A61K45/06 , A61K2300/00
摘要： A combination of medicines are administered daily for the relief of the symptoms of an Anxiety Disorder or an Adjustment Disorder With Anxiety. The combination comprises a centrally-acting beta-blocker which passes the brain blood barrier, preferably the beta-blocker betaxolol, and a serotonin-enhancer, for example, the serotonin agonist buspirone or the serotonin reuptake inhibitor sertraline.
摘要翻译：药物的组合每天用于缓解焦虑症或焦虑症调节障碍的症状。该组合物包含中枢作用的β-阻断剂，其通过脑血管屏障，优选β-阻滞剂倍他洛尔，和5-羟色胺增强剂，例如5-羟色胺激动剂丁螺环酮或5-羟色胺再摄取抑制剂舍曲林。

6. 发明授权

US5871517A Convulsive therapy apparatus to stimulate and monitor the extent of therapeutic value of the treatment 失效
标题翻译：惊厥治疗仪刺激和监测治疗价值的程度
公开(公告)号：US5871517A
公开(公告)日：1999-02-16
申请号：US784128
申请日：1997-01-15
申请人： Richard Stephen Abrams , Conrad Melton Swartz
发明人： Richard Stephen Abrams , Conrad Melton Swartz
IPC分类号： A61N1/38 , A61N2/04 , A61N1/32 , A61N1/36
CPC分类号： A61N1/38 , A61B5/0476 , A61B5/0484 , A61B5/4094 , A61B5/4833
摘要： In medical convulsive therapy (CV), comprising electroconvulsive therapy (ECT) and magnetoconvulsive therapy (MCT), a computer system is used to analyze the effectiveness of the treatment. In one embodiment the effectiveness is determined by measuring the physiological effects on the heart (ECG) muscles (EMG) and brain (EEG).
摘要翻译：在包括电惊厥治疗（ECT）和磁震惊治疗（MCT）的医学惊厥治疗（CV）中，使用计算机系统来分析治疗的有效性。在一个实施例中，通过测量对心脏（ECG）肌肉（EMG）和脑（EEG）的生理作用来确定有效性。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式